THER-34. MEK BLOCKADE SYNERGISTICALLY INCREASES THE ANTI-TUMOR EFFECTS OF mTOR INHIBITION IN GLIOMAS

Abnormal signaling of the RAS/RAF and mTOR pathways predominates in pediatric low-grade gliomas (PLGGs). MLN0128 is a second-generation pan-mTOR inhibitor (TORC1/2). Rapalink-1, a third-generation bivalent mTOR inhibitor that combines rapamycin with MLN0128 by an inert chemical linker, shows potent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Zhang, Jie, Liu, Kevin, Dik, Rogier, Yang, Xiaodong, Waanders, Angela, Resnick, Adam, Wright, Karen, Weiss, William, Haas-Kogan, Daphne, Mueller, Sabine
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Translational Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477411/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.238
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars